Kazia Therapeutics Ltd ADR
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 |
|---|---|---|
Revenue | $22 | $2,480 |
Gross Profit | 22 | 2,480 |
EBITDA | -8,433 | -18,644 |
EBIT | -9,368 | -19,578 |
Net Income | -10,453 | -17,954 |
Net Change In Cash | 22 | 2,480 |
Free Cash Flow | -4,210 | -3,246 |
Cash | 3,064 | 1,657 |
Basic Shares | 850 | 575 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $42 | $2,308 | $ | $10 |
Gross Profit | 42 | 2,308 | 10 | |
EBITDA | -13,283 | -26,593 | -22,277 | -23,515 |
EBIT | -14,217 | -28,462 | -24,146 | -25,384 |
Net Income | -20,702 | -26,778 | -20,465 | -25,014 |
Net Change In Cash | 42 | 2,308 | 10 | |
Free Cash Flow | -13,278 | -9,581 | -15,156 | -22,762 |
Cash | 4,345 | 1,657 | 5,241 | 7,361 |
Basic Shares | 1,095 | 479 | 368 | 265 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$12.30 |
2024-09-30 | -$31.22 |
2021-03-31 | -$0.006 |
2020-12-31 | -$0.006 |
